share_log

Cingulate | 4: Statement of changes in beneficial ownership of securities-Officer Brams Matthew

Cingulate | 4:持股變動聲明-高管 Brams Matthew

美股sec公告 ·  03/07 07:05
牛牛AI助理已提取核心訊息
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. (CING), was involved in a transaction on 03/04/2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the potential impact on their investment and the confidence of insiders in the company's prospects.
Matthew Brams, EVP and Chief Medical Officer of Cingulate Inc. (CING), was involved in a transaction on 03/04/2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the potential impact on their investment and the confidence of insiders in the company's prospects.
Cingulate Inc.(CING)執行副總裁兼首席醫學官馬修·布拉姆斯於2024年4月3日參與了一筆交易。公告中未披露交易的具體細節,例如行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量。這些信息對於投資者了解其投資的潛在影響以及內部人士對公司前景的信心至關重要。
Cingulate Inc.(CING)執行副總裁兼首席醫學官馬修·布拉姆斯於2024年4月3日參與了一筆交易。公告中未披露交易的具體細節,例如行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量。這些信息對於投資者了解其投資的潛在影響以及內部人士對公司前景的信心至關重要。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。